Cargando…
The HPV Cellular Transactivator Brn-3a Can Be Used to Predict Cervical Adenocarcinoma and Squamous Carcinoma Precancer Lesions in the Developed and Developing Worlds
The cellular transactivator Brn-3a has previously been shown to be expressed at elevated levels in the cervix of women with squamous cell carcinoma of the cervix (SCC) and to activate the expression of HPV E6 mRNA. In this study, we show that common and rare cervical precancer lesions, including tho...
Autores principales: | Ndisang, Daniel, Lorenzato, Felipe, Sindos, Michael, Khan, Ashfaq, Singer, Albert, Latchman, David S. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2836136/ https://www.ncbi.nlm.nih.gov/pubmed/20224757 http://dx.doi.org/10.1155/2009/359457 |
Ejemplares similares
-
Genetic and Epigenetic Variations of HPV52 in Cervical Precancer
por: Bee, Katharine J., et al.
Publicado: (2021) -
The HPV E2 Transcriptional Transactivation Protein Stimulates Cellular DNA Polymerase Epsilon
por: Chojnacki, Michaelle, et al.
Publicado: (2018) -
BRN2 as a key gene drives the early primate telencephalon development
por: Zhu, Xiaoqing, et al.
Publicado: (2022) -
Searching HPV genome for methylation sites involved in molecular progression to cervical precancer
por: Kottaridi, Christine, et al.
Publicado: (2019) -
A comparison of methylation levels in HPV18, HPV31 and HPV33 genomes reveals similar associations with cervical precancers()
por: Vasiljević, Nataša, et al.
Publicado: (2014)